_id
6919ed9b3c536f8df2318479
Ticker
RTW.LSE
Name
RTW Venture Fund Ltd
Exchange
LSE
Address
40 10th Avenue, New York, NY, United States, 10014
Country
UK
Sector
Financial Services
Industry
Asset Management
Currency
USD
Website
https://www.rtwfunds.com/rtw-biotech-opportunities
Description
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Last Close
2.19
Volume
19566
Current Price
2.22
Change
0
Last Updated
2025-12-30T11:28:29.267Z
Image
https://logo.clearbit.com/www.rtwfunds.com
Ipo Date
-
Market Cap
71530579200
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
29788265
Cost Of Revenue
3669044
Gross Profit
29788265
Operating Expenses
6820920
Operating Income
22967345
Interest Expense
3625918
Pretax Income
-40736360
Net Income
-40736360
Eps
-0.12341971048135628
Dividends Per Share
-
Shares Outstanding
326373649
Income Tax Expense
-
EBITDA
-
Operating Margin
77.10198965935075
Total Other Income Expense Net
-63703705
Cash
2661257
Short Term Investments
-
Receivables
367454
Inventories
-
Total Current Assets
228574810
Property Plant Equipment
-
Total Assets
766120872
Payables
48767645
Short Term Debt
126303780
Long Term Debt
-
Total Liabilities
180921935
Equity
561014995
Bs_currency_symbol
USD
Depreciation
-22967345
Change In Working Capital
29225074
Cash From Operations
30697774
Capital Expenditures
0
Cash From Investing
-15033170
Cash From Financing
-6708388
Net Change In Cash
-4096602
Cf_currency_symbol
-
PE
-
PB
1.306099315188536
ROE
-7.261189159480488
ROA
-5.317223624733723
FCF
30697774
Fcf Percent
1.030532459678333
Piotroski FScore
2
Health Score
54
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
6.8
Garp Investing Score
6
Growth Investing Score
4.5
Momentum Investing Score
6
Net Net Investing Score
4
Quality Investing Score
6
Value Investing Score
5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
29788265
Quarters > 0 > income Statement > cost Of Revenue
3669044
Quarters > 0 > income Statement > gross Profit
29788265
Quarters > 0 > income Statement > operating Expenses
6820920
Quarters > 0 > income Statement > operating Income
22967345
Quarters > 0 > income Statement > interest Expense
3625918
Quarters > 0 > income Statement > pretax Income
-40736360
Quarters > 0 > income Statement > net Income
-40736360
Quarters > 0 > income Statement > eps
-0.12341971048135628
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
330063649
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
77.10198965935075
Quarters > 0 > income Statement > total Other Income Expense Net
-63703705
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
2661257
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
367454
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
228574810
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
766120872
Quarters > 0 > balance Sheet > payables
48767645
Quarters > 0 > balance Sheet > short Term Debt
126303780
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
180921935
Quarters > 0 > balance Sheet > equity
561014995
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-40736360
Quarters > 0 > cash Flow > depreciation
-22967345
Quarters > 0 > cash Flow > change In Working Capital
29225074
Quarters > 0 > cash Flow > cash From Operations
30697774
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-15033170
Quarters > 0 > cash Flow > cash From Financing
-6708388
Quarters > 0 > cash Flow > net Change In Cash
-4096602
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.12341971048135628
Quarters > 0 > ratios > PB
1.306099315188536
Quarters > 0 > ratios > ROE
-7.261189159480488
Quarters > 0 > ratios > ROA
-5.317223624733723
Quarters > 0 > ratios > FCF
30697774
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
1.030532459678333
Quarters > 0 > health Score
54
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
5316943
Quarters > 1 > income Statement > cost Of Revenue
1336000
Quarters > 1 > income Statement > gross Profit
23899000
Quarters > 1 > income Statement > operating Expenses
-302000
Quarters > 1 > income Statement > operating Income
-1338000
Quarters > 1 > income Statement > interest Expense
4772000
Quarters > 1 > income Statement > pretax Income
-51645000
Quarters > 1 > income Statement > net Income
-51645000
Quarters > 1 > income Statement > eps
-0.15383630113727756
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
335714000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-48396000
Quarters > 1 > income Statement > operating Margin
-25.1648362602345
Quarters > 1 > income Statement > total Other Income Expense Net
-50307328
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
5360022
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
4237674
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
5360022
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
760016409
Quarters > 1 > balance Sheet > payables
23570906
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
127372724
Quarters > 1 > balance Sheet > equity
606921161
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-51644975
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-41238913
Quarters > 1 > cash Flow > cash From Operations
-130594329
Quarters > 1 > cash Flow > capital Expenditures
2
Quarters > 1 > cash Flow > cash From Investing
104352292
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-59592537
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.15383630113727756
Quarters > 1 > ratios > PB
1.2279767585826522
Quarters > 1 > ratios > ROE
-8.509342451481931
Quarters > 1 > ratios > ROA
-6.795248022072639
Quarters > 1 > ratios > FCF
-130594331
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-24.561920449401093
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
18266000
Quarters > 2 > income Statement > cost Of Revenue
3436000
Quarters > 2 > income Statement > gross Profit
14830000
Quarters > 2 > income Statement > operating Expenses
4851000
Quarters > 2 > income Statement > operating Income
87287000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
85825000
Quarters > 2 > income Statement > net Income
85825000
Quarters > 2 > income Statement > eps
0.2637036809438948
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
325460000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
87287000
Quarters > 2 > income Statement > operating Margin
477.8659805102376
Quarters > 2 > income Statement > total Other Income Expense Net
-1462000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
6757859
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
59620735
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
217906802
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
777204995
Quarters > 2 > balance Sheet > payables
67433468
Quarters > 2 > balance Sheet > short Term Debt
14884837
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
92916335
Quarters > 2 > balance Sheet > equity
655393270
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
85824944
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
55483915
Quarters > 2 > cash Flow > cash From Operations
6256412
Quarters > 2 > cash Flow > capital Expenditures
2
Quarters > 2 > cash Flow > cash From Investing
-104352292
Quarters > 2 > cash Flow > cash From Financing
97079650
Quarters > 2 > cash Flow > net Change In Cash
4036306
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.2637036809438948
Quarters > 2 > ratios > PB
1.1024238927567873
Quarters > 2 > ratios > ROE
13.095190922543345
Quarters > 2 > ratios > ROA
11.042775143255481
Quarters > 2 > ratios > FCF
6256410
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.3425166976896967
Quarters > 2 > health Score
88
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
-11152985
Quarters > 3 > income Statement > cost Of Revenue
-556000
Quarters > 3 > income Statement > gross Profit
2284000
Quarters > 3 > income Statement > operating Expenses
3651000
Quarters > 3 > income Statement > operating Income
-1368000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
50701000
Quarters > 3 > income Statement > net Income
50701000
Quarters > 3 > income Statement > eps
0.2407054857929594
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
210635000
Quarters > 3 > income Statement > income Tax Expense
52281000
Quarters > 3 > income Statement > EBITDA
51155065
Quarters > 3 > income Statement > operating Margin
12.265774588596685
Quarters > 3 > income Statement > total Other Income Expense Net
51828000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
2721553
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
57887214
Quarters > 3 > balance Sheet > inventories
-106564662
Quarters > 3 > balance Sheet > total Current Assets
109286215
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
446234427
Quarters > 3 > balance Sheet > payables
5329681
Quarters > 3 > balance Sheet > short Term Debt
1197921
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
17211470
Quarters > 3 > balance Sheet > equity
399283811
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
50701212
Quarters > 3 > cash Flow > depreciation
1580000
Quarters > 3 > cash Flow > change In Working Capital
-5644338
Quarters > 3 > cash Flow > cash From Operations
-12690235
Quarters > 3 > cash Flow > capital Expenditures
5
Quarters > 3 > cash Flow > cash From Investing
-3823424
Quarters > 3 > cash Flow > cash From Financing
-2093410
Quarters > 3 > cash Flow > net Change In Cash
-6750173
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.2407054857929594
Quarters > 3 > ratios > PB
1.1711211101418786
Quarters > 3 > ratios > ROE
12.697985393652736
Quarters > 3 > ratios > ROA
11.361965131390455
Quarters > 3 > ratios > FCF
-12690240
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
1.137833503766032
Quarters > 3 > health Score
87
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
43501000
Annuals > 0 > income Statement > cost Of Revenue
4772000
Annuals > 0 > income Statement > gross Profit
38729000
Annuals > 0 > income Statement > operating Expenses
4549000
Annuals > 0 > income Statement > operating Income
38891000
Annuals > 0 > income Statement > interest Expense
4772000
Annuals > 0 > income Statement > pretax Income
34180000
Annuals > 0 > income Statement > net Income
34180000
Annuals > 0 > income Statement > eps
0.10502058624715786
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
325460000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
38890704
Annuals > 0 > income Statement > operating Margin
89.40254247028804
Annuals > 0 > income Statement > total Other Income Expense Net
112084657
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
5360022
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
4237674
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5360022
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
760016409
Annuals > 0 > balance Sheet > payables
23570906
Annuals > 0 > balance Sheet > short Term Debt
95151493
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
127372724
Annuals > 0 > balance Sheet > equity
606921161
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
34179969
Annuals > 0 > cash Flow > depreciation
3971000
Annuals > 0 > cash Flow > change In Working Capital
14245000
Annuals > 0 > cash Flow > cash From Operations
-124337917
Annuals > 0 > cash Flow > capital Expenditures
38516602
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
97079650
Annuals > 0 > cash Flow > net Change In Cash
-27258267
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
0.10502058624715786
Annuals > 0 > ratios > PB
1.1725053198466415
Annuals > 0 > ratios > ROE
5.631703456126487
Annuals > 0 > ratios > ROA
4.497271321414325
Annuals > 0 > ratios > FCF
-162854519
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-3.7436959840003676
Annuals > 0 > health Score
58
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
87856000
Annuals > 1 > income Statement > cost Of Revenue
4269757
Annuals > 1 > income Statement > gross Profit
67017890
Annuals > 1 > income Statement > operating Expenses
7161334
Annuals > 1 > income Statement > operating Income
-2991000
Annuals > 1 > income Statement > interest Expense
1560000
Annuals > 1 > income Statement > pretax Income
83192000
Annuals > 1 > income Statement > net Income
83192000
Annuals > 1 > income Statement > eps
0.39827270899359446
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
208882000
Annuals > 1 > income Statement > income Tax Expense
83192379
Annuals > 1 > income Statement > EBITDA
84752808
Annuals > 1 > income Statement > operating Margin
-3.4044345292296483
Annuals > 1 > income Statement > total Other Income Expense Net
85707000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2721553
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
57887214
Annuals > 1 > balance Sheet > inventories
-106564662
Annuals > 1 > balance Sheet > total Current Assets
109286215
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
446234427
Annuals > 1 > balance Sheet > payables
5329681
Annuals > 1 > balance Sheet > short Term Debt
1197921
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
17211470
Annuals > 1 > balance Sheet > equity
399283811
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
83192379
Annuals > 1 > cash Flow > depreciation
2991000
Annuals > 1 > cash Flow > change In Working Capital
-26393171
Annuals > 1 > cash Flow > cash From Operations
33540554
Annuals > 1 > cash Flow > capital Expenditures
37322272
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-2093411
Annuals > 1 > cash Flow > net Change In Cash
31447143
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.39827270899359446
Annuals > 1 > ratios > PB
1.143849263149815
Annuals > 1 > ratios > ROE
20.835305040704494
Annuals > 1 > ratios > ROA
18.64311558372882
Annuals > 1 > ratios > FCF
-3781718
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
-0.043044504643962846
Annuals > 1 > health Score
75
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
-36509659
Annuals > 2 > income Statement > cost Of Revenue
3751464
Annuals > 2 > income Statement > gross Profit
-36509659
Annuals > 2 > income Statement > operating Expenses
2927078
Annuals > 2 > income Statement > operating Income
-38656749
Annuals > 2 > income Statement > interest Expense
779988
Annuals > 2 > income Statement > pretax Income
-39436737
Annuals > 2 > income Statement > net Income
-39436737
Annuals > 2 > income Statement > eps
-0.16999985774697066
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
231981000
Annuals > 2 > income Statement > income Tax Expense
-4511283
Annuals > 2 > income Statement > EBITDA
-38656749
Annuals > 2 > income Statement > operating Margin
105.88088209752931
Annuals > 2 > income Statement > total Other Income Expense Net
-779988
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
6966168
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
439798
Annuals > 2 > balance Sheet > inventories
-82332994
Annuals > 2 > balance Sheet > total Current Assets
7405966
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
401540398
Annuals > 2 > balance Sheet > payables
5561560
Annuals > 2 > balance Sheet > short Term Debt
12438334
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
53616409
Annuals > 2 > balance Sheet > equity
326079521
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-39436737
Annuals > 2 > cash Flow > depreciation
4511283
Annuals > 2 > cash Flow > change In Working Capital
-7515367
Annuals > 2 > cash Flow > cash From Operations
-15671629
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
26025231
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
2412687
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.16999985774697066
Annuals > 2 > ratios > PB
1.5555299362084134
Annuals > 2 > ratios > ROE
-12.094208455366322
Annuals > 2 > ratios > ROA
-9.821362233146962
Annuals > 2 > ratios > FCF
-15671629
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
0.4292461071739947
Annuals > 2 > health Score
52
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-60919566
Annuals > 3 > income Statement > cost Of Revenue
215606
Annuals > 3 > income Statement > gross Profit
-60919566
Annuals > 3 > income Statement > operating Expenses
3425224
Annuals > 3 > income Statement > operating Income
-64344790
Annuals > 3 > income Statement > interest Expense
215606
Annuals > 3 > income Statement > pretax Income
-64344790
Annuals > 3 > income Statement > net Income
-64344790
Annuals > 3 > income Statement > eps
-0.27000004196144584
Annuals > 3 > income Statement > dividends Per Share
4974920
Annuals > 3 > income Statement > shares Outstanding
238314000
Annuals > 3 > income Statement > income Tax Expense
-64344790
Annuals > 3 > income Statement > EBITDA
-64344790
Annuals > 3 > income Statement > operating Margin
105.62253513099552
Annuals > 3 > income Statement > total Other Income Expense Net
-215606
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
6484057
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
295790
Annuals > 3 > balance Sheet > inventories
-41555458
Annuals > 3 > balance Sheet > total Current Assets
6779847
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
439363363
Annuals > 3 > balance Sheet > payables
38511866
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
52002637
Annuals > 3 > balance Sheet > equity
387360726
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-64344790
Annuals > 3 > cash Flow > depreciation
7581378
Annuals > 3 > cash Flow > change In Working Capital
38754192
Annuals > 3 > cash Flow > cash From Operations
-44872017
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
39093587
Annuals > 3 > cash Flow > net Change In Cash
-5778430
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.27000004196144584
Annuals > 3 > ratios > PB
1.3451894475228758
Annuals > 3 > ratios > ROE
-16.61107739662797
Annuals > 3 > ratios > ROA
-14.645005801268868
Annuals > 3 > ratios > FCF
-44872017
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
0.7365780806777251
Annuals > 3 > health Score
52
Valuation > metrics > PE
-0.12341971048135628
Valuation > metrics > PB
1.306099315188536
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-7.261189159480488
Profitability > metrics > ROA
-17.821893847357895
Profitability > metrics > Net Margin
-1.3675304687936676
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.3224903730068748
Risk > metrics > Interest Coverage
6.334215224944414
Risk > final Score
85
Risk > verdict
Low
Liquidity > metrics > Current Ratio
1.3056088964832495
Liquidity > metrics > Quick Ratio
1.3056088964832495
Liquidity > final Score
83
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
100
Prev Valuations > 2
100
Prev Profitabilities > 0
0
Prev Profitabilities > 1
86
Prev Profitabilities > 2
55
Prev Risks > 0
59
Prev Risks > 1
100
Prev Risks > 2
48
Prev Liquidities > 0
21
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:03:42.268Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-30
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-11
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.12
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-12-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2024-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.15
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.15
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-06-30
Earnings History > 3 > report Date
2022-09-15
Earnings History > 3 > date
2022-06-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.49
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2021-12-31
Earnings History > 4 > report Date
2022-03-31
Earnings History > 4 > date
2021-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.21
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.21
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-06-30
Earnings History > 5 > report Date
2021-09-16
Earnings History > 5 > date
2021-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.09
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-03-31
Earnings History > 6 > report Date
2021-04-29
Earnings History > 6 > date
2021-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.73
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-06-30
Earnings History > 7 > report Date
2020-09-24
Earnings History > 7 > date
2020-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.06
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0.06
Earnings History > 7 > surprise Percent
-
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ARTW Biotech Opp. - Boston Scientific to acquire Penumbra Research Tree
Read more →Showing 2 of 3
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of RTW Venture Fund Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.12
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.